189 related articles for article (PubMed ID: 36804531)
21. Hypoxia-inducible long noncoding RNA NPSR1-AS1 promotes the proliferation and glycolysis of hepatocellular carcinoma cells by regulating the MAPK/ERK pathway.
He H; Chen T; Mo H; Chen S; Liu Q; Guo C
Biochem Biophys Res Commun; 2020 Dec; 533(4):886-892. PubMed ID: 33008585
[TBL] [Abstract][Full Text] [Related]
22. The effect of HIF-1α on glucose metabolism, growth and apoptosis of pancreatic cancerous cells.
He G; Jiang Y; Zhang B; Wu G
Asia Pac J Clin Nutr; 2014; 23(1):174-80. PubMed ID: 24561986
[TBL] [Abstract][Full Text] [Related]
23. Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells.
Chen F; Chen J; Yang L; Liu J; Zhang X; Zhang Y; Tu Q; Yin D; Lin D; Wong PP; Huang D; Xing Y; Zhao J; Li M; Liu Q; Su F; Su S; Song E
Nat Cell Biol; 2019 Apr; 21(4):498-510. PubMed ID: 30936474
[TBL] [Abstract][Full Text] [Related]
24. HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer.
Huang Y; Chen Z; Lu T; Bi G; Li M; Liang J; Hu Z; Zheng Y; Yin J; Xi J; Lin Z; Zhan C; Jiang W; Wang Q; Tan L
J Exp Clin Cancer Res; 2021 Dec; 40(1):398. PubMed ID: 34930376
[TBL] [Abstract][Full Text] [Related]
25. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
[TBL] [Abstract][Full Text] [Related]
26. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
[TBL] [Abstract][Full Text] [Related]
27. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture.
Dong T; Yan Y; Chai H; Chen S; Xiong X; Sun D; Yu Y; Deng L; Cheng F
Biomed Pharmacother; 2015 Feb; 69():277-84. PubMed ID: 25661370
[TBL] [Abstract][Full Text] [Related]
28. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms.
Marín-Hernández A; Gallardo-Pérez JC; Ralph SJ; Rodríguez-Enríquez S; Moreno-Sánchez R
Mini Rev Med Chem; 2009 Aug; 9(9):1084-101. PubMed ID: 19689405
[TBL] [Abstract][Full Text] [Related]
29. MARK2 potentiate aerobic glycolysis-mediated cell growth in breast cancer through regulating mTOR/HIF-1α and p53 pathways.
Ponnusamy L; Natarajan SR; Manoharan R
J Cell Biochem; 2022 Apr; 123(4):759-771. PubMed ID: 35048405
[TBL] [Abstract][Full Text] [Related]
30. AGR2-induced glucose metabolism facilitated the progression of endometrial carcinoma via enhancing the MUC1/HIF-1α pathway.
Gong W; Ekmu B; Wang X; Lu Y; Wan L
Hum Cell; 2020 Jul; 33(3):790-800. PubMed ID: 32304027
[TBL] [Abstract][Full Text] [Related]
31. Circular RNA circRNF20 promotes breast cancer tumorigenesis and Warburg effect through miR-487a/HIF-1α/HK2.
Cao L; Wang M; Dong Y; Xu B; Chen J; Ding Y; Qiu S; Li L; Karamfilova Zaharieva E; Zhou X; Xu Y
Cell Death Dis; 2020 Feb; 11(2):145. PubMed ID: 32094325
[TBL] [Abstract][Full Text] [Related]
32. Targeting the ROS/PI3K/AKT/HIF-1α/HK2 axis of breast cancer cells: Combined administration of Polydatin and 2-Deoxy-d-glucose.
Zhang T; Zhu X; Wu H; Jiang K; Zhao G; Shaukat A; Deng G; Qiu C
J Cell Mol Med; 2019 May; 23(5):3711-3723. PubMed ID: 30920152
[TBL] [Abstract][Full Text] [Related]
33. VEGF/Nrp1/HIF-1α promotes proliferation of hepatocellular carcinoma through a positive feedback loop.
Wang YB; Zheng KW; Hu YY; Salameen H; Zhu ZY; Wu FF; Ding X
Med Oncol; 2023 Oct; 40(12):339. PubMed ID: 37875691
[TBL] [Abstract][Full Text] [Related]
34. PRKAR2B-HIF-1α loop promotes aerobic glycolysis and tumour growth in prostate cancer.
Xia L; Sun J; Xie S; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Sha J; Xue W
Cell Prolif; 2020 Nov; 53(11):e12918. PubMed ID: 33025691
[TBL] [Abstract][Full Text] [Related]
35. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.
Feng J; Wu L; Ji J; Chen K; Yu Q; Zhang J; Chen J; Mao Y; Wang F; Dai W; Xu L; Wu J; Guo C
J Exp Clin Cancer Res; 2019 May; 38(1):204. PubMed ID: 31101057
[TBL] [Abstract][Full Text] [Related]
36. LINC00365 inhibited lung adenocarcinoma progression and glycolysis via sponging miR-429/KCTD12 axis.
Zhang CW; Zhou B; Liu YC; Su LW; Meng J; Li SL; Wang XL
Environ Toxicol; 2022 Aug; 37(8):1853-1866. PubMed ID: 35426242
[TBL] [Abstract][Full Text] [Related]
37. Qiliqiangxin attenuates hypoxia-induced injury in primary rat cardiac microvascular endothelial cells via promoting HIF-1α-dependent glycolysis.
Wang Y; Han X; Fu M; Wang J; Song Y; Liu Y; Zhang J; Zhou J; Ge J
J Cell Mol Med; 2018 May; 22(5):2791-2803. PubMed ID: 29502357
[TBL] [Abstract][Full Text] [Related]
38. USP11 promotes glycolysis by regulating HIF-1α stability in hepatocellular carcinoma.
Qiao L; Hu W; Li L; Chen X; Liu L; Wang J
J Cell Mol Med; 2024 Jan; 28(2):e18017. PubMed ID: 38229475
[TBL] [Abstract][Full Text] [Related]
39. Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways.
Kumar S; Donti TR; Agnihotri N; Mehta K
Int J Cancer; 2014 Jun; 134(12):2798-807. PubMed ID: 24477458
[TBL] [Abstract][Full Text] [Related]
40. TFB2M activates aerobic glycolysis in hepatocellular carcinoma cells through the NAD
Chang H; Li J; Luo Y; Wu B; Yuan C; Geng X
J Gastroenterol Hepatol; 2021 Oct; 36(10):2978-2988. PubMed ID: 33982328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
